Search PDMR transactions

Notifier
Name of person with notification obligation
Rolf Ingvar Lennart Karlsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Rolf Ingvar Lennart Karlsson
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Elicera Therapeutics AB
Issuer´s LEI code
549300I35L0R4INBFG27
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Interim share Elicera Therapeutics AB SE0015382080 Subscription 51,600 Quantity 1.85 SEK 11/03/2025 NASDAQ STOCKHOLM AB
Option Elicera Therapeutics AB TO2 SE0021626314 Acquisition 18,000 Quantity 0.50 SEK 10/03/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Elicera Therapeutics AB SE0015382080 Subscription 11/03/2025 NASDAQ STOCKHOLM AB 51,600 (Quantity) 1.85 SEK
Elicera Therapeutics AB TO2 SE0021626314 Acquisition 10/03/2025 NASDAQ STOCKHOLM AB 18,000 (Quantity) 0.50 SEK
<< Back